Searchable abstracts of presentations at key conferences in endocrinology

ea0028p329 | Steroids | SFEBES2012

Risk of iatrogenic Cushings syndrome and adrenal suppression in antiretroviral regimes including CYP450 3A4 inhibitors

McManus Frances , White Bethanna , MacConnachie Alisdair , Perry Colin

A 60 year old female from Zimbabwe with an eight year history of HIV infection presented with malaise and facial swelling. She had been established on antiretroviral treatment (Kivexa (lamivudine / abacavir) and Kaletra (lopinivir / ritonavir)) since shortly after her initial diagnosis. One month earlier she had received an injection of intramuscular triamcinolone acetate to treat an inflammatory polyarthropathy. She was also prescribed inhaled salmeterol xinafoate 50 mcg/flut...

ea0025p158 | Diabetes, metabolism and cardiovascular | SFEBES2011

Effect of diet/lifestyle advice on weight change in an unselected polycystic ovary syndrome (PCOS) population

Sinha Khushboo , Albeyatti Abdullah , White Davinia , Franks Stephen , Webber Lisa

Objectives: To examine the effect on weight change of diet/lifestyle advice to maintain/achieve a healthy weight in an unselected PCOS population.Methods: All overweight patients attending the Reproductive Endocrine clinic with PCOS are routinely given lifestyle advice for weight loss by their consultant, offered referral to see a dietician and, when clinically appropriate, prescribed orlistat. Clinical notes were reviewed for 50 consecutive patients wit...

ea0025p181 | Endocrine tumours and neoplasia | SFEBES2011

Laparoscopic adrenalectomy for Conn’s syndrome benefits is beneficial to patients and to health finances

White Heather , Jayaweera Samantha , Sadler Gregory , Mihai Radu

Background: Primary hyperaldosteronism is allegedly present in 10% of hypertensive patients. Conn’s syndrome is present in a third of such patients and adrenalectomy has the potential to cure/improve the control of hypertension. This study assesses the benefits/costs of laparoscopic adrenalectomy (LA) in a cohort of consecutive patients with Conn’s syndrome operated in a tertiary referral centre.Methods: Clinical, radiological, operative and pa...

ea0024op1.3 | (1) | BSPED2010

Intensive insulin therapy in adolescent type 2 diabetes

White B , Hindmarsh P C , Viner R M

Background: Glucolipotoxicity contributes to declining B-cell function and acceleration of type 2 diabetes (T2DM). Intensive insulin therapy has been shown to rapidly reverse glucolipotoxicity and improve B-cell function, particularly if given soon after diagnosis. Recent trials in adults have shown promise, with 50% in remission at 1 year after intensive insulin therapy.Methods: We report 4 cases of young people with T2DM treated with intravenous insuli...

ea0023p19 | (1) | BSPED2009

Congenital adrenal hyperplasia: incidence, prevalence and rationale for inclusion on the newborn screening programme in the Republic of Ireland

McDonnell Ciara , White Mary , Kelleher Suzanne , Murphy Nuala

Introduction: Congenital Adrenal Hyperplasia (CAH) carries a high risk of morbidity and mortality in undetected affected infants and has an estimated incidence of 1:15 000 based on newborn screening programmes internationally. This project aimed to identify cases and mode of diagnosis of CAH in the Republic of Ireland (ROI) to establish the case if any for screening.Methods: (i) A retrospective questionnaire was sent to all consultant paediatricians in R...

ea0021p171 | Diabetes and metabolism | SFEBES2009

Biomarkers of the hypothalamic-pituitary-adrenal (HPA) axis for analysis of in vivo 11β-hydroxysteroid dehydrogenase 1 inhibition

Harno Erika , Yu Alice , Leighton Brendan , Turnbull Andrew , White Anne

Inhibition of 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1) as a means of reducing tissue corticosteroids is showing marked potential as a treatment for type 2 diabetes. However, reduction in tissue corticosteroids may lead to upregulation of the HPA axis. Therefore this study investigates the effect of 11β-HSD1 inhibition on HPA axis biomarkers and examines whether time of dosing impacts on the biomarkers.C57Bl6/Jax mice were fed 60% kcal...

ea0019p203 | Growth and development | SFEBES2009

Human fetal mesenchymal stem cells can differentiate into white and brown adipocytes, and reveal a role for ERRα in human UCP1 expression

Morganstein D , Wu P , Fisk N , White R , Parker M

Adipocytes have a key role in obesity and precursor cells can differentiate into white or brown adipocytes, with different metabolic functions. However the process by which stem cells commit to these lineages, and the factors that distinguish white adipogenesis from brown, are poorly understood.Fetal mesenchymal stem cells (fMSCs) can differentiate into adipocytes, but neither the regulation of this process, nor the phenotype differentiated cells has bee...

ea0019p335 | Steroids | SFEBES2009

Epigenetic silencing of the GR and defining the pro-apoptotic actions of GR expression in human cancer cell lines

Kay Paul , Matthews Laura , Sommer Paula , White Anne , Ray David

Although glucocorticoids (Gc) are used to treat a range of pathologies, an individuals response to therapy varies considerably. There is a distinct correlation between certain cell types and steroid sensitivity. Aberrant glucocorticoid receptor (GR) function is well-characterised in lymphoid malignant cells but not small cell lung cancer (SCLC) (DMS79) or osteosarcoma (U2OS) cell lines, which are both Gc resistant.Previously we have shown reduced GR cont...

ea0015p171 | Endocrine tumours and neoplasia | SFEBES2008

An example of Doege Potter syndrome

Boyle James G , White Beth A , Gunatillake Nirosha , Jones Greg C

A 69-year-old man presented in a life threatening hypoglycaemic coma which following resuscitation required continuous intravenous dextrose to maintain euglycaemia. Random blood sugar was confirmed at 0.7 mmol/l. Past medical history included a large (19×14.5 cm) recurrent malignant fibrous tumour of the pleura which was resected in 1989 but recurred in 2006. At that time the tumour was thought not to be responsive to chemotherapy and radiotherapy and debulking surgery wa...

ea0015p173 | Endocrine tumours and neoplasia | SFEBES2008

The management of multiple endocrine neoplasia type 1: 5-year experience of a multidisciplinary clinic

White Helen , Blair Jo , Weber Astrid , Pinkney Jonathan , MacFarlane Ian

The multiple endocrine neoplasia (MEN) clinic at our hospital was established in 2002 with the aim of providing integrated, comprehensive and expert regional care to patients with MEN syndrome. The clinical team consists of an adult endocrinologist, a paediatric endocrinologist, a clinical geneticist and an endocrine surgeon.In 2002, 16 patients with MEN type 1 from five different kindred were seen. These patients had previously been attending a combinat...